Zoetis Inc. Acquisitions, Net of Cash Acquired
Zoetis Inc. (ZTS) reported Acquisitions, Net of Cash Acquired of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-16.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2021-02-16
- Zoetis Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2019-12-31 was $0.00.
- Zoetis Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2018-12-31 was $0.00.
- Zoetis Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2018-09-30 was $1.88B.
- Zoetis Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2018-06-30 was $0.00.
- Zoetis Inc. payments to acquire businesses, net of cash acquired for fiscal 2020 was $0.00.
- Zoetis Inc. payments to acquire businesses, net of cash acquired for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Zoetis Inc. payments to acquire businesses, net of cash acquired for fiscal 2018 was $1.88B.
- Zoetis Inc. payments to acquire businesses, net of cash acquired for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 12 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-16 | ||||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $0.00 10-K · filed 2021-02-16 | |||||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-07 | ||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $1.88B derived: sum of 2 quarters · filed 2021-02-16 | $1.88B derived: sum of 3 quarters · filed 2021-02-16 | $1.88B 10-K · filed 2021-02-16 | |||
| 2018-09-30 | $1.88B derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.88B derived: sum of 2 quarters · filed 2019-11-07 | $1.88B 10-Q · filed 2019-11-07 | $1.88B derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $0.00 10-Q · filed 2018-08-02 | $0.00 derived: sum of 3 quarters · filed 2020-02-13 | -$3.00M derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-02 | $0.00 derived: sum of 2 quarters · filed 2020-02-13 | -$3.00M derived: sum of 3 quarters · filed 2020-02-13 | -$3.00M derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$3.00M derived: sum of 2 quarters · filed 2020-02-13 | -$3.00M derived: sum of 3 quarters · filed 2020-02-13 | $0.00 10-K · filed 2020-02-13 | $82.00M 10-K · filed 2018-02-15 | ||
| 2017-10-01 | -$3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$3.00M derived: sum of 2 quarters · filed 2018-11-01 | $0.00 10-Q · filed 2018-11-01 | $82.00M 10-Q · filed 2017-11-02 | $0.00 derived: sum of 4 quarters · filed 2018-11-01 | ||
| 2017-07-02 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $3.00M 10-Q · filed 2018-08-02 | $3.00M derived: sum of 3 quarters · filed 2018-08-02 | $71.00M derived: sum of 4 quarters · filed 2018-08-02 | |||
| 2017-04-02 | $3.00M 10-Q · filed 2018-05-02 | $3.00M derived: sum of 2 quarters · filed 2018-05-02 | $71.00M derived: sum of 3 quarters · filed 2018-05-02 | $79.00M derived: sum of 4 quarters · filed 2018-05-02 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $68.00M derived: sum of 2 quarters · filed 2018-02-15 | $76.00M derived: sum of 3 quarters · filed 2018-02-15 | $88.00M 10-K · filed 2018-02-15 | |||
| 2016-10-02 | $68.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $76.00M derived: sum of 2 quarters · filed 2017-11-02 | $88.00M 10-Q · filed 2017-11-02 | $742.00M derived: sum of 4 quarters · filed 2018-02-15 | |||
| 2016-07-03 | $8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $20.00M 10-Q · filed 2017-08-08 | $674.00M derived: sum of 3 quarters · filed 2018-02-15 | $674.00M derived: sum of 4 quarters · filed 2018-02-15 | |||
| 2016-04-03 | $12.00M 10-Q · filed 2017-05-04 | $666.00M derived: sum of 2 quarters · filed 2018-02-15 | $666.00M derived: sum of 3 quarters · filed 2018-02-15 | $665.00M derived: sum of 4 quarters · filed 2018-02-15 | |||
| 2015-12-31 | $654.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $654.00M derived: sum of 2 quarters · filed 2018-02-15 | $653.00M derived: sum of 3 quarters · filed 2018-02-15 | $883.00M 10-K · filed 2018-02-15 | $229.00M 10-K · filed 2016-02-24 | ||
| 2015-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$1.00M derived: sum of 2 quarters · filed 2016-11-03 | $229.00M 10-Q · filed 2016-11-03 | $229.00M derived: sum of 4 quarters · filed 2017-02-16 | |||
| 2015-06-28 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $229.00M 10-Q · filed 2016-08-05 | $229.00M derived: sum of 3 quarters · filed 2017-02-16 | $229.00M derived: sum of 4 quarters · filed 2017-02-16 | |||
| 2015-03-29 | $230.00M 10-Q · filed 2016-05-06 | $230.00M derived: sum of 2 quarters · filed 2017-02-16 | $230.00M derived: sum of 3 quarters · filed 2017-02-16 | $230.00M derived: sum of 4 quarters · filed 2017-02-16 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $0.00 derived: sum of 2 quarters · filed 2017-02-16 | $0.00 derived: sum of 3 quarters · filed 2017-02-16 | $0.00 10-K · filed 2017-02-16 | $15.00M 10-K · filed 2015-02-27 | ||
| 2014-09-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $0.00 derived: sum of 2 quarters · filed 2015-11-05 | $0.00 10-Q · filed 2015-11-05 | $15.00M 10-Q · filed 2014-11-10 | $0.00 derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $0.00 10-Q · filed 2015-08-06 | $15.00M 10-Q · filed 2014-08-12 | $0.00 derived: sum of 3 quarters · filed 2016-02-24 | $0.00 derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-30 | $0.00 10-Q · filed 2015-05-07 | $0.00 derived: sum of 2 quarters · filed 2016-02-24 | $0.00 derived: sum of 3 quarters · filed 2016-02-24 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $0.00 derived: sum of 2 quarters · filed 2016-02-24 | $0.00 10-K · filed 2016-02-24 | $4.00M 10-K · filed 2014-03-26 | |||
| 2013-09-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $0.00 10-Q · filed 2014-11-10 | |||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-12 | ||||||
| 2012-12-31 | $0.00 10-K · filed 2015-02-27 | ||||||
| 2012-07-01 | $1.00M 10-Q · filed 2013-08-14 | ||||||
| 2011-12-31 | $345.00M 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |